Efficacy and Safety of Hydroxyurea in the Treatment of Sickle Cell Anemia Children in Jos, North Central Nigeria

被引：1
|
作者：
Ofakunrin, Akinyemi Olugbenga David [1 ]
Adekola, Kehinde U. [2 ]
Oguche, Stephen [3 ]
Okpe, Edache Sylvanus [3 ]
Sagay, Atiene Solomon [4 ]
机构：
[1] Univ Jos, Dept Paediat, Jos, Nigeria
[2] Northwestern Univ, Feinberg Sch Med, Robert H Lurie Comprehens Canc Ctr, Chicago, IL 60611 USA
[3] Univ Jos, Jos Univ Teaching Hosp, Dept Paediat, Jos, Nigeria
[4] Univ Jos, Jos Univ Teaching Hosp, Dept Obstet & Gynaecol, Jos, Nigeria
来源：
BLOOD | 2018年 / 132卷
关键词：
D O I：
10.1182/blood-2018-99-115598
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
1081
引用
收藏
页数：2
相关论文
共 50 条
  • [21] Level of Utilization and Provider-Related Barriers to Hydroxyurea Use in the Treatment of Sickle Cell Disease in Jos, Nigeria
    Ofakunrin, Akinyemi Olugbenga David
    Adekola, Kehinde
    Okpe, Edache Sylvanus
    Oguche, Stephen
    Afolaranmi, Tolulope
    Kanhu, Patience
    Dami, Nantok
    Sagay, Atiene Solomon
    BLOOD, 2019, 134
  • [22] Hydroxyurea Treatment Reduces Infection Rates in African Children with Sickle Cell Anemia
    Williams, Thomas N.
    Latham, Teresa S.
    Tomlinson, George A.
    Olupot-Olupot, Peter
    Santos, Brigida
    Tshilolo, Leon
    Lane, Adam C.
    Aygun, Banu
    Stuber, Susan E.
    Smart, Luke R.
    Ware, Russell E.
    BLOOD, 2024, 144 : 545 - 546
  • [23] Pulmonary Function in Children with Sickle Cell Anemia Following Treatment with Hydroxyurea.
    Record, Elizabeth
    New, Tamara
    Brown, Randall
    Graham, LeRoy
    Brown, R. Clark
    BLOOD, 2008, 112 (11) : 511 - 512
  • [24] Acceptability and Safety of Hydroxyurea for Primary Prevention of Stroke in Children with Sickle Cell Disease in Nigeria
    DeBaun, Michael R.
    Galadanci, Najibah Aliyu
    Abdullahi, Shehu U.
    Tabari, Musa A.
    Abubakar, Shehi
    Belonwu, Raymond
    Salihu, Auwal
    Neville, Kathleen A.
    Kirkham, Fenella J.
    Inusa, Baba P. D.
    Shyr, Yu
    Phillips, Sharon
    Kassim, Adetola A.
    Jordan, Lori C.
    Aliyu, Muktar H.
    Covert, Brittany V.
    BLOOD, 2014, 124 (21)
  • [25] Shared Decision Making for Hydroxyurea Treatment Initiation in Children With Sickle Cell Anemia
    Crosby, Lori E.
    Shook, Lisa M.
    Ware, Russell E.
    Brinkman, William B.
    PEDIATRIC BLOOD & CANCER, 2015, 62 (02) : 184 - 185
  • [26] The Current Role of Hydroxyurea in the Treatment of Sickle Cell Anemia
    Rubio, Montserrat Lopez
    Marina, Maria Arguello
    JOURNAL OF CLINICAL MEDICINE, 2024, 13 (21)
  • [27] Hydroxyurea for sickle cell anemia
    Bachmeyer, Claude
    Aractingi, Selim
    Lionnet, Francois
    NEW ENGLAND JOURNAL OF MEDICINE, 2008, 359 (01): : 98 - 98
  • [28] Leukemogenesis of hydroxyurea in the treatment of Sickle cell anemia.
    Rauch, A
    Borromeo, M
    Ghafoor, A
    Khoyratty, B
    Maheshwari, J
    BLOOD, 1999, 94 (10) : 415A - 415A
  • [29] TREATMENT OF SICKLE-CELL-ANEMIA WITH HYDROXYUREA AND ERYTHROPOIETIN
    GOLDBERG, MA
    BRUGNARA, C
    DOVER, GJ
    SCHAPIRA, L
    CHARACHE, S
    BUNN, HF
    NEW ENGLAND JOURNAL OF MEDICINE, 1990, 323 (06): : 366 - 372
  • [30] Efficacy and safety of thalidomide with hydroxyurea in sickle cell anemia: a quasi-experimental clinical trial
    Priyanka Samal
    Anindita Paul
    Harshwardhan Bahirat
    Ajit Kumar Bishoyi
    Venkatarao Epari
    Blood Research, 2025, 60 (1)
12345